The trademark application IPJEDRO was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on June 22, 2008, and still open for oppositions.
The application was filed in Swedish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the metabolism, respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system and pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology, and diabetes..